test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 1.44%
1.01%
$2.904M
73,762 shares@ $39.38 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
Decreased -6.11%
1%
$2.872M
112,459 shares@ $25.55 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -14.4%
0.88%
$2.533M
212,185 shares@ $11.95 avg price
RVMDRevolution Medicines Inc
Recent Activity
Increased 38.62%
0.87%
$2.52M
55,562 shares@ $45.36 avg price
COGTCogent Biosciences Inc
Recent Activity
Decreased -19.73%
0.85%
$2.437M
225,633 shares@ $10.8 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
New Position
0.82%
$2.371M
88,838 shares@ $26.69 avg price
DYNDyne Therapeutics Inc
Recent Activity
New Position
0.82%
$2.352M
65,482 shares@ $35.92 avg price
PFSIPennymac Finl Svcs Inc New
Recent Activity
Increased 46.09%
0.77%
$2.204M
19,337 shares@ $113.98 avg price
MLTXMoonlake Immunotherapeutics
Recent Activity
Increased 3.06%
0.76%
$2.195M
43,541 shares@ $50.42 avg price
BABAAlibaba Group Hldg Ltd
Recent Activity
Increased 26.78%
0.75%
$2.16M
20,357 shares@ $106.13 avg price